Perspective Therapeutics (CATX) Prepaid Assets (2011 - 2026)
Perspective Therapeutics (CATX) reported Prepaid Assets of $4.4 million for Q1 2026, up 10.17% on a YoY basis from $4.0 million in Q1 2025, and up 19.72% sequentially from $3.6 million in Q4 2025.
Perspective Therapeutics (CATX) Prepaid Assets (2011 - 2026) Analysis & Trends
Perspective Therapeutics (CATX) has 16 years of Prepaid Assets data on file, last reported at $4.4 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 10.17% year-over-year to $4.4 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (up 10.17% YoY), and the FY2025 full-year result was $3.6 million, up 669.2% from the prior year.
- Prepaid Assets improved to $4.4 million in Q1 2026, from $3.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.4 million in Q1 2026 to a low of $315000.0 in Q4 2023.
- A 5-year average of $1.8 million and a median of $1.2 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 1511.11% in 2022 and declined 28.89% in 2023, its largest moves.
- Tracing CATX's Prepaid Assets over 5 years: stood at $443000.0 in 2022, then declined by 28.89% to $315000.0 in 2023, then soared by 50.48% to $474000.0 in 2024, then jumped by 669.2% to $3.6 million in 2025, then advanced by 19.72% to $4.4 million in 2026.
- Business Quant data shows CATX's Prepaid Assets at $4.4 million in Q1 2026, $3.6 million in Q4 2025, and $4.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.37 Mn |
| Dec 31, 2025 | 3.65 Mn |
| Sep 30, 2025 | 4.18 Mn |
| Jun 30, 2025 | 4.16 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 474,000.00 |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 315,000.00 |
| Sep 30, 2023 | 961,000.00 |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 443,000.00 |
| Sep 30, 2022 | 662,000.00 |
| Jun 30, 2022 | 435,000.00 |
| Mar 31, 2022 | 551,000.00 |
| Dec 31, 2021 | 535,000.00 |
| Sep 30, 2021 | 306,000.00 |
| Jun 30, 2021 | 27,000.00 |